SLC2A1 and non-small cell lung carcinoma: Additionally, the enhanced levels of glucose consumption (Figure 7A), lactate production (Figure 7B), ECAR (Figure 7C), GLUT1, PDK1, LDHA, p‐PI3K, p‐AKT (Figure 7E), and reduced level of OCR (Figure 7D) in Exos‐treated NSCLC cells were partially reversed by depletion of miR‐3126‐5p.